Biosimilars 2019

Aug 02-03, 2019


Chicago, United States of America

14th International Conference on Biologics and Biosimilars


LexisConferences is pleased to welcome everyone to attend our forthcoming conference 14th International Conference on Biologics and Biosimilars which is going to place during August 2-3, 2019 in the beautiful and exciting city of Chicago, USA.

Biosimilars 2019 brings together scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials and CROs from around the world. The passage of approval for biosimilars finds much requirement for discussion also focussing the latest developments in the field of biologics and Biosimilars.

This conference will focus on biosimilar conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market.

With the theme "A new doorway to novel yet affordable medicines", we will try to reason more with why we need Biosimilars in our lives and how can we make it safer and reliable. We will be covering various topics related to the field of Biopharmaceutical, especially Biosimilars in the form of Keynote Sessions, Plenary Sessions, Poster Presentations and Workshops.


Details of Biosimilars 2019:

Conference Name



Biosimilars 2019

Chicago, USA

August 2-3, 2019

Francois-Xavier Frapaise
Biosimilars Consultant
Loyola Medical Center


Dr. Francois-Xavier Frapaise, M.D has over 30 years of international drug development experience at major pharmaceutical companies including Sanofi, Bayer, Boehringer, Merck and Abbott; he has hold multiple Clevel positions (CSO,CMO,CEO) in different Phar

Researches :

  • Biosimilars
Milind Antani
Lead - Pharma Healthcare Practice
Nishith Desai Associates


Dr. Milind Antani, a renowned surgeon turned lawyer, leads the Pharma & Healthcare practice at multi-skilled, research-based international law firm, Nishith Desai Associates where he represents high net-worth clients in matters allied to JVs, M&As, VC and

Researches :

  • Pharmaceutics and Biotechnology, Regulatory
Peter K Kalinka
Chairman and Principal Consultant
Longmore 60 Biotech Inc


Peter H Kalinka is Chairman and Principal Consultant at Longmore 60 Biotech Inc. He possesses in-depth knowledge of drug development and directed numerous development projects including Therapeutic Proteins, Monoclonal Antibodies and Fusion Proteins. His

Researches :

  • Cloning Process development Scale up, (e-coli, CHO, Hybridoma etc.) Analytical development, Bioassays, Pre-clinical, clinical Phases, to manufacturing and Regulatory affairs.
Brij M Gandhi
CEO and founder
Neo BioMed Services


Dr. Brij. M. Gandhi, M.Sc., Ph.D. is presently CEO and founder of Neo BioMed Services (, providing services and consultancy in health areas and regulatory issues related to biopharmaceuticals, pharmaceuticals, including stem cell and reg

Researches :

  • Immunology of parasitic, bacterial and viral infections including amoebic diseases; hepatitis; liver diseases, IVD, food and nutritional health issues. CBRNe

Program Overview

Our Collaborations, Sponsors, Media Partners